Literature DB >> 2216628

Febrile status epilepticus.

J Maytal1, S Shinnar.   

Abstract

As part of a study of status epilepticus in children (Maytal J, Shinnar S, Moshe SL, Alvarez LA. Pediatrics. 1989; 83:323-331); 44 children with febrile convulsions lasting more than 30 minutes were followed for a mean of 28 months (range 4 to 72). Thirty children were followed prospectively. Children with prior afebrile seizures or evidence of acute central nervous system infection were excluded. Nine (20%) children had prior neurological deficits. The duration of the febrile seizure was 0.5 to 1 hour in 41 cases (85%), 1 to 2 hours in 5 (10%), and greater than 2 hours in 2 children (5%). No child died or developed new neurological deficits following the seizures. The risk of recurrent seizures was increased, but only in the group with prior neurological abnormality. Six (66%) of these children had subsequent febrile seizures compared with 12 (34%) of the normal children (P = .08). Three (33%) had recurrent febrile status epilepticus compared with only 1 (3%) normal child (P = .023). The 2 children in the prospective arm of the study with recurrent febrile status epilepticus were both neurologically abnormal (P = .035). All 3 of the children who subsequently had afebrile seizures (2 prospective) were neurologically abnormal (P = .006 overall, P = .035 for prospective only). It is concluded that the occurrence of febrile status epilepticus in a neurologically impaired child is a risk factor for subsequent febrile as well as afebrile seizures. The occurrence of febrile status epilepticus in an otherwise normal child does not significantly increase the risk for subsequent febrile (brief or prolonged) or afebrile seizures in the first few years following the episode.

Entities:  

Mesh:

Year:  1990        PMID: 2216628

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  24 in total

Review 1.  Outcome of convulsive status epilepticus: a review.

Authors:  Claire L Novorol; Richard F M Chin; Rod C Scott
Journal:  Arch Dis Child       Date:  2007-11       Impact factor: 3.791

2.  Quantitative Evaluation of Medial Temporal Lobe Morphology in Children with Febrile Status Epilepticus: Results of the FEBSTAT Study.

Authors:  A C McClelland; W A Gomes; S Shinnar; D C Hesdorffer; E Bagiella; D V Lewis; J A Bello; S Chan; J MacFall; M Chen; J M Pellock; D R Nordli; L M Frank; S L Moshé; R C Shinnar; S Sun
Journal:  AJNR Am J Neuroradiol       Date:  2016-09-15       Impact factor: 3.825

Review 3.  Do seizures damage the brain? The epidemiological evidence.

Authors:  C M Verity
Journal:  Arch Dis Child       Date:  1998-01       Impact factor: 3.791

4.  Cognitive functioning one month and one year following febrile status epilepticus.

Authors:  Erica F Weiss; David Masur; Shlomo Shinnar; Dale C Hesdorffer; Veronica J Hinton; Melanie Bonner; Julie Rinaldi; Virginia Van de Water; James Culbert; Ruth C Shinnar; Syndi Seinfeld; William Gallentine; Douglas R Nordli; L Mathew Frank; Leon Epstein; Solomon L Moshé; Shumei Sun
Journal:  Epilepsy Behav       Date:  2016-10-26       Impact factor: 2.937

Review 5.  Developmental seizures induced by common early-life insults: short- and long-term effects on seizure susceptibility.

Authors:  F E Jensen; T Z Baram
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2000

Review 6.  Origins of temporal lobe epilepsy: febrile seizures and febrile status epilepticus.

Authors:  Katelin P Patterson; Tallie Z Baram; Shlomo Shinnar
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

7.  Status epilepticus in Indian children in a tertiary care center.

Authors:  Sheffali Gulati; Veena Kalra; M R Sridhar
Journal:  Indian J Pediatr       Date:  2005-02       Impact factor: 1.967

8.  Outcome of childhood status epilepticus and lengthy febrile convulsions: findings of national cohort study.

Authors:  C M Verity; E M Ross; J Golding
Journal:  BMJ       Date:  1993-07-24

Review 9.  Anti-epileptogenic clinical trial designs in epilepsy: issues and options.

Authors:  Dieter Schmidt; Daniel Friedman; Marc A Dichter
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

Review 10.  Febrile seizures: an update.

Authors:  C Waruiru; R Appleton
Journal:  Arch Dis Child       Date:  2004-08       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.